Baseline Characteristics of COVID-19 in Cancer Patients 
=============

<img src="https://img.shields.io/badge/Study%20Status-Repo%20Created-lightgray.svg" alt="Study Status: Repo Created">

- Analytics use case(s): **Characterization**
- Study type: **Clinical application**
- Tags: **COVID-19, Oncology**
- Study lead: **Talita Duarte-Salles, Shilpa Ratwani**
- Study lead forums tag: **[tduarte](https://forums.ohdsi.org/u/tduarte/), [shilparatwani](https://forums.ohdsi.org/u/shilparatwani/)**
- Study start date: **April 7, 2020**
- Study end date: **-**
- Protocol: **-**
- Publications: **-**
- Results explorer: **-**

The OHDSI Community seeks to characterize COVID-19 in patients with cancer. This study repository will be updated as a protocol is created and the community seeks to engage data owners who could be part of this analysis.
